JP2007530675A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530675A5
JP2007530675A5 JP2007506135A JP2007506135A JP2007530675A5 JP 2007530675 A5 JP2007530675 A5 JP 2007530675A5 JP 2007506135 A JP2007506135 A JP 2007506135A JP 2007506135 A JP2007506135 A JP 2007506135A JP 2007530675 A5 JP2007530675 A5 JP 2007530675A5
Authority
JP
Japan
Prior art keywords
composition
antigen
antibody
binding fragment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506135A
Other languages
English (en)
Japanese (ja)
Other versions
JP4758984B2 (ja
JP2007530675A (ja
Filing date
Publication date
Priority claimed from US10/842,011 external-priority patent/US20050025763A1/en
Priority claimed from US10/982,357 external-priority patent/US7709610B2/en
Application filed filed Critical
Publication of JP2007530675A publication Critical patent/JP2007530675A/ja
Publication of JP2007530675A5 publication Critical patent/JP2007530675A5/ja
Application granted granted Critical
Publication of JP4758984B2 publication Critical patent/JP4758984B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007506135A 2004-03-29 2004-11-08 抗ｃｓ１抗体の治療的使用 Expired - Lifetime JP4758984B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US55762004P 2004-03-29 2004-03-29
US55762204P 2004-03-29 2004-03-29
US55762104P 2004-03-29 2004-03-29
US60/557,621 2004-03-29
US60/557,620 2004-03-29
US60/557,622 2004-03-29
US10/842,011 2004-05-07
US10/842,011 US20050025763A1 (en) 2003-05-08 2004-05-07 Therapeutic use of anti-CS1 antibodies
US10/982,357 2004-11-05
US10/982,357 US7709610B2 (en) 2003-05-08 2004-11-05 Therapeutic use of anti-CS1 antibodies
PCT/US2004/037430 WO2005102387A2 (en) 2004-03-29 2004-11-08 Therapeutic use of anti-cs1 antibodies

Publications (3)

Publication Number Publication Date
JP2007530675A JP2007530675A (ja) 2007-11-01
JP2007530675A5 true JP2007530675A5 (enrdf_load_stackoverflow) 2009-01-08
JP4758984B2 JP4758984B2 (ja) 2011-08-31

Family

ID=44597272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506135A Expired - Lifetime JP4758984B2 (ja) 2004-03-29 2004-11-08 抗ｃｓ１抗体の治療的使用

Country Status (8)

Country Link
JP (1) JP4758984B2 (enrdf_load_stackoverflow)
CY (1) CY1115003T1 (enrdf_load_stackoverflow)
DK (1) DK2301576T3 (enrdf_load_stackoverflow)
ES (1) ES2393539T3 (enrdf_load_stackoverflow)
HR (1) HRP20120975T1 (enrdf_load_stackoverflow)
IL (1) IL243687A0 (enrdf_load_stackoverflow)
PT (1) PT2301576E (enrdf_load_stackoverflow)
SI (1) SI2301576T1 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138282A1 (en) * 2008-06-02 2009-12-10 Dana-Farber Cancer Institute, Inc. Xbp1, cd138, and cs1 peptides
EP3919069A1 (en) 2012-11-05 2021-12-08 Dana-Farber Cancer Institute, Inc. Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
WO2015166056A1 (en) * 2014-05-02 2015-11-05 Cellectis Cs1 specific multi-chain chimeric antigen receptor
FI3794042T3 (fi) 2018-05-18 2024-05-31 Daiichi Sankyo Co Ltd Anti-muc1-eksatekaani-vasta-aine-lääkekonjugaatti
CN112442126B (zh) * 2019-09-04 2022-07-29 杭州济元基因科技有限公司 一种抗人cs1抗原的单克隆抗体及其car-t细胞

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123617A1 (en) * 1999-12-23 2002-09-05 Starling Gary C. Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereof

Similar Documents

Publication Publication Date Title
JP2007503465A5 (enrdf_load_stackoverflow)
Möller et al. Monoclonal antibodies recognize different parts of Z-DNA.
CN107206076B (zh) 靶向b-细胞成熟抗原的抗体及其用途
JP2009521913A5 (enrdf_load_stackoverflow)
CA2690293A1 (en) Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
WO2002016401A3 (en) Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
Eklund et al. Anti‐idiotypic protein domains selected from protein A‐based affibody libraries
JP2009534297A5 (enrdf_load_stackoverflow)
JP2010511388A5 (enrdf_load_stackoverflow)
JP2017114866A5 (enrdf_load_stackoverflow)
FI3401334T3 (fi) Monoklonaalisia vasta-aineita Claudin-18:aa vastaan syövän hoitamiseksi
JP2009515897A5 (enrdf_load_stackoverflow)
JP2009539348A5 (enrdf_load_stackoverflow)
IN2009KN02655A (enrdf_load_stackoverflow)
JP2011505146A5 (enrdf_load_stackoverflow)
JP2009502171A5 (enrdf_load_stackoverflow)
JP2007510664A5 (enrdf_load_stackoverflow)
BRPI0511910A (pt) anticorpos antil-il-13 e complexos
HRP20171274T1 (hr) U potpunosti ljudska antitijela specifična za cadm1
JP2007526908A5 (enrdf_load_stackoverflow)
EP3300739A3 (en) Antibodies and related molecules that bind to 161p2f10b proteins
Nevanen et al. Efficient enantioselective separation of drug enantiomers by immobilised antibody fragments
JP2007530675A5 (enrdf_load_stackoverflow)
JP2018527895A5 (enrdf_load_stackoverflow)
JP2024003141A5 (ja) 抗体およびその治療上の使用